Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kanion Yujin Pharmaceutical is a specialized pharmaceutical manufacturer based in Tonghua, Jilin Province, China, and operates as a wholly-owned subsidiary of Jiangsu Kanion Pharmaceutical. The company focuses on the development and production of Traditional Chinese Medicines (TCM) and chemical drug formulations, particularly in the fields of cardiovascular, gynecological, and gastrointestinal health. Its core product portfolio includes the Yujin Capsule, a proprietary TCM used for inflammatory and circulatory conditions, alongside various tablets and capsules. Kanion Yujin maintains modern, GMP-certified production lines that support the large-scale manufacturing of botanical extracts and finished dosages. By integrating with the Kanion Group's extensive R&D network, the company contributes to the modernization and standardization of herbal therapies. It serves as a key production base for the parent group in Northeast China, targeting the domestic healthcare market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 通化康缘玉金药业.